Genix Pharmaceuticals Corporation announced earnings results for the second quarter ended April 30, 2021. For the second quarter, the company announced net loss was CAD 402,271 compared to CAD 46,552 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to Basic EPS - Continuing Operations of CAD 0.00 a year ago. For the half year, net loss was CAD 795,508 compared to CAD 84,324 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to Basic EPS - Continuing Operations of CAD 0.00 a year ago.